|
I.A. Ilovayskaya, P.A. Zakharova, E.D. Metlushko
Monitoring of patients with acromegaly in the real-life clinical practice settings
|
№11-12 / 2022
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), A.V. Andreeva (2)
Current approaches to the diagnostics and treatment of acromegaly
|
№4 / 2019
|
|
M.B. Antsiferov (1), Zh.E. Belaya (2)
INCREASING THE DOSE OF SOMATOSTATIN ANALOGUES OF IN PATIENTS WITH ACTIVE FORM OF ACROMEGALY: LITERATURE REVIEW AND PROSPECTS FOR APPLICATION
|
№16 / 2017
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
MOSCOW REGISTRY OF PATIENTS WITH ACROMEGALY: LONG-TERM RESULTS OF OBSERVATIONS
|
№16 / 2016
|
|
V.A. Gorbunova
NEW POTENTIALS FOR THE USE OF SOMATOSTATIN ANALOGS IN NEUROENDOCRINE TUMORS
|
№8 / 2016
|
|
A.A. Markovich (1), M.B. Antsiferov (2)
NEW APPROACHES TO DIAGNOSIS AND TREATMENT OF NEUROENDOCRINE TUMORS
|
№17 / 2015
|
|
M.B. Antsiferov (1), V.S. Pronin (2)
OPTIMIZATION OF TREATMENT OF PATIENTS WITH ACROMEGALY: INCREASE THE INTERVAL BETWEEN INJECTIONS OF LANREOTIDE
|
№16 / 2014
|
|
V.Pronin, Y.Poteshkin С. 6467
Use Of Somastatin Analogues In The Treatment Of Patients With Acromegaly: Options For The Drug Somatuline® Autogel® Use
|
№3 / 2010
|
Русский
